Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms. Scope of the Report: The classification of Tuberculosis diagnostics includes culture-based diagnostics, sputum smear microscopy diagnostics, rapid molecular diagnostics and so on. And the proportion of Culture-based Diagnostic in 2017 is about 34.84%, and the proportion is in decreasing trend from 2013 to 2017. Tuberculosis Diagnostics is widely used in hospital, diagnostic laboratories and other field. The most proportion of Tuberculosis Diagnostics is hospital, and the revenue in 2017 is 542 M USD. Europe is the largest consumption place, with a Revenue market share nearly 42.03% in 2017. Following Europe, Africa is the second largest consumption place with the Revenue market share of 35.76%. The global Tuberculosis Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tuberculosis Diagnostics. Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%. This report studies the Tuberculosis Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tuberculosis Diagnostics market by product type and applications/end industries. Market Segment by Companies, this report covers Danaher Roche Thermo Fisher Scientific BD Abbott Hologic Qiagen BioMerieux Hain Lifescience Oxford Immunotec Epistem Akonni Biosystems Creative Diagnostics Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Culture-based Sputum Smear Microscopy Rapid Molecular Others Market Segment by Applications, can be divided into Hospital Diagnostic Laboratories Others
Table of Contents 1 Tuberculosis Diagnostics Market Overview 1.1 Product Overview and Scope of Tuberculosis Diagnostics 1.2 Classification of Tuberculosis Diagnostics by Types 1.2.1 Global Tuberculosis Diagnostics Revenue Comparison by Types (2019-2024) 1.2.2 Global Tuberculosis Diagnostics Revenue Market Share by Types in 2018 1.2.3 Culture-based 1
